Citations (14)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Amy Barton Pai, Soo Min Jang & Nicole Wegrzyn. (2016) Iron-based phosphate binders – a new element in management of hyperphosphatemia. Expert Opinion on Drug Metabolism & Toxicology 12:1, pages 115-127.
Read now
Read now
Jean-Marc Idée, Nathalie Fretellier, Caroline Robic & Claire Corot. (2014) The role of gadolinium chelates in the mechanism of nephrogenic systemic fibrosis: A critical update. Critical Reviews in Toxicology 44:10, pages 895-913.
Read now
Read now
Articles from other publishers (12)
Patrick Bücker, Henning Richter, Alexander Radbruch, Michael Sperling, Marcus Brand, Markus Holling, Veerle Van Marck, Werner Paulus, Astrid Jeibmann & Uwe Karst. (2021) Deposition patterns of iatrogenic lanthanum and gadolinium in the human body depend on delivered chemical binding forms. Journal of Trace Elements in Medicine and Biology 63, pages 126665.
Crossref
Crossref
Xin Pan, Jinxia Li, Xia He, Jianjun Deng, Faqin Dong, Kui Wang & Siwang Yu. (2019) Gadolinium chloride promotes proliferation of HEK293 human embryonic kidney cells by activating EGFR/PI3K/Akt and MAPK pathways. BioMetals 32:4, pages 683-693.
Crossref
Crossref
Yongsheng Yang, Adil Mohammad, Robert T. Berendt, Alan Carlin, Mansoor A. Khan & Patrick J. Faustino. (2016) Evaluation of the In Vitro Efficacy of Sevelamer Hydrochloride and Sevelamer Carbonate. Journal of Pharmaceutical Sciences 105:2, pages 864-875.
Crossref
Crossref
Krishna Ramaswamy, David W. Killilea, Pankaj Kapahi, Arnold J. Kahn, Thomas Chi & Marshall L. Stoller. (2015) The elementome of calcium-based urinary stones and its role in urolithiasis. Nature Reviews Urology 12:10, pages 543-557.
Crossref
Crossref
Xiaojian Jiang, Yongsheng Yang & Ethan Stier. 2014. FDA Bioequivalence Standards. FDA Bioequivalence Standards
297
334
.
Yongsheng Yang, Srikant Bykadi, Alan S. Carlin, Rakhi B. Shah, Lawrence X. Yu & Mansoor A. khan. (2013) Comparative Evaluation of the In Vitro Efficacy of Lanthanum Carbonate Chewable Tablets. Journal of Pharmaceutical Sciences 102:4, pages 1370-1381.
Crossref
Crossref
Yongsheng Yang, Rakhi B. Shah, Lawrence X. Yu & Mansoor A. Khan. (2013)
In Vitro
Bioequivalence Approach for a Locally Acting Gastrointestinal Drug: Lanthanum Carbonate
. Molecular Pharmaceutics 10:2, pages 544-550.
Crossref
Crossref
Haesuk Park, Karen L. Rascati, Michael S. Keith, Paul Hodgkins, Michael Smyth, David Goldsmith & Ron Akehurst. (2011) Cost-Effectiveness of Lanthanum Carbonate versus Sevelamer Hydrochloride for the Treatment of Hyperphosphatemia in Patients with End-Stage Renal Disease: A US Payer Perspective. Value in Health 14:8, pages 1002-1009.
Crossref
Crossref
Takashi Shigematsu, Akihide Tokumoto, Akihisa Nakaoka & Hiroaki Arisaka. (2011) Effect of Lanthanum Carbonate Treatment on Bone in Japanese Dialysis Patients With Hyperphosphatemia. Therapeutic Apheresis and Dialysis 15:2, pages 176-184.
Crossref
Crossref
S A Handley, K B Raja, C Sharpe & R J Flanagan. (2011) Measurement of serum lanthanum in patients treated with lanthanum carbonate by inductively coupled plasma-mass spectrometry. Annals of Clinical Biochemistry: International Journal of Laboratory Medicine 48:2, pages 178-182.
Crossref
Crossref
Li Hong Wang, Na Jiang, Bo Zhao, Xiao Dong Li, Tian Hong Lu, Xiao Lan Ding & Xiao Hua Huang. (2010) Structural basis for the decrease in the outward potassium channel current induced by lanthanum. JBIC Journal of Biological Inorganic Chemistry 15:7, pages 989-993.
Crossref
Crossref
Raghu Samy, Patrick J. Faustino, Wallace Adams, Lawrence Yu, Mansoor A. Khan & Yongsheng Yang. (2010) Development and validation of an ion chromatography method for the determination of phosphate-binding of lanthanum carbonate. Journal of Pharmaceutical and Biomedical Analysis 51:5, pages 1108-1112.
Crossref
Crossref